id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-013306-35jiycem	Tarazan, Nehal	Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials	2020-10-23		.txt	text/plain	4726	239	48	Eligible studies met all of the following criteria: (1) the design was a parallel-group RCT; (2) the population was adults with ARDS of any severity; (3) the intervention included any continuous NMBA infusion, at any dose or duration, compared to placebo or no continuous NMBA infusion but allowing the use of as needed NMBA boluses; (4) outcomes included any of: mortality at 28 days, ICU discharge, or hospital discharge (truncated at 90 days); long-term outcomes (physical function at 3 months; quality of life at 3 months; cognitive function at 3 months); ICU-acquired weakness; duration of mechanical ventilation; ventilator-free days (VFDs); ICU or hospital length of stay; barotrauma (including pneumothorax, pneumomediastinum, pneumatocele, or subcutaneous emphysema); or changes in oxygenation measured by using the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PO 2 /FiO 2 ratio).	./cache/cord-013306-35jiycem.txt	./txt/cord-013306-35jiycem.txt